Abha Chopra Selected Research

Epstein-Barr Virus Infections

1/2016

Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abha Chopra Research Topics

Disease

9	Infections 10/2023 - 02/2011
5	Hypersensitivity (Allergy) 02/2022 - 01/2017
4	HIV Infections (HIV Infection) 11/2017 - 03/2013
3	Drug Hypersensitivity Syndrome 01/2019 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 10/2018
2	Human Influenza (Influenza) 01/2023 - 05/2009
2	Neoplasms (Cancer) 12/2022 - 01/2020
2	Drug Hypersensitivity (Drug Allergy) 12/2022 - 01/2021
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 02/2024
1	Blister (Bulla) 02/2024
1	Inclusion Body Myositis 12/2023
1	Breast Neoplasms (Breast Cancer) 12/2022
1	Retinal Diseases 07/2022
1	Color Vision Defects (Color Blindness) 07/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2022
1	Stomach Diseases 01/2022
1	Persistent Infection 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Lung Neoplasms (Lung Cancer) 11/2020
1	Eosinophilia 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Pleural Effusion (Pleural Effusions) 12/2018
1	Iron Deficiencies 10/2018
1	Viremia 11/2017
1	Vascular Diseases (Vascular Disease) 11/2017
1	Epstein-Barr Virus Infections 01/2016
1	Multiple Sclerosis 01/2016
1	Hepatitis C 01/2015
1	Chronic Hepatitis B 01/2012

Drug/Important Bio-Agent (IBA)

8	HLA Antigens (Human Leukocyte Antigens)IBA 02/2024 - 02/2011
4	AntigensIBA 01/2021 - 05/2015
3	VaccinesIBA 01/2023 - 09/2011
3	abacavir (Ziagen)FDA Link 01/2022 - 01/2019
3	HLA-B57 antigenIBA 01/2022 - 01/2019
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 12/2018
3	Peptides (Polypeptides)IBA 01/2017 - 05/2009
2	RNA (Ribonucleic Acid)IBA 10/2023 - 12/2022
2	SaltsIBA 01/2023 - 10/2018
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 01/2019
2	Vancomycin FDA LinkGeneric 01/2019 - 01/2019
2	Glycoproteins (Glycoprotein)IBA 01/2018 - 11/2017
2	EpitopesIBA 01/2018 - 11/2017
1	ProteomeIBA 02/2024
1	5'-Nucleotidase (5' Nucleotidase)IBA 12/2023
1	AntibodiesIBA 12/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2022
1	InterferonsIBA 12/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022
1	Poly I-CIBA 12/2022
1	Fluorouracil (Carac)FDA LinkGeneric 12/2022
1	HLA-B Antigens (HLA-B)IBA 12/2022
1	Histone DemethylasesIBA 07/2022
1	GSK-J4IBA 07/2022
1	Histones (Histone)IBA 07/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022
1	5' Untranslated Regions (5' UTR)IBA 01/2022
1	Viral ProteinsIBA 01/2021
1	B7-H1 AntigenIBA 11/2020
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	Granzymes (Granzyme)IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Broadly Neutralizing AntibodiesIBA 01/2018
1	HLA-DR7 Antigen (HLA DR7 Antigen)IBA 11/2017
1	gag Gene Products (gag Protein)IBA 01/2017
1	Nevirapine (Viramune)FDA Link 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 04/2016
1	Antiviral Agents (Antivirals)IBA 01/2015
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	NucleotidesIBA 04/2014
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2012
1	Hepatitis B e AntigensIBA 01/2012

Therapy/Procedure

5	Therapeutics 07/2022 - 03/2014
1	Drug Therapy (Chemotherapy) 12/2022
1	Immunotherapy 11/2020